“…Cross-sectional and longitudinal investigations from these laboratories were able to establish that SWAP was capable of characterizing glaucomatous visual field defect patterns, [50][51][52][53][60][61][62][63][64] could detect glaucomatous visual field loss up to 10 years earlier than standard perimetric testing, 70 could predict future glaucomatous damage on conventional perimetric testing, [55][56][57][60][61][62][63][64][65][66] and was able to determine a greater amount of progressive glaucomatous loss as compared to standard perimetric testing. 52,55,61,68 A collaborative study was able to determine the optimal clinical test procedures for SWAP, which consisted of a highluminance (100 cd/m 2 ) broadband yellow background with a dominant wavelength of 530 nm (OG 530 Kodak Wratten filter), a narrow band (10 nm) large (Goldmann Size V) "blue" stimulus (dominant wavelength of 440 nm, Omega filter) presented for 200 ms. 54 These conditions were able to minimize the effect of lens attenuation of short wavelength light, maximize the dynamic range of SWAP, and provide the greatest amount of isolation of short wavelength sensitive mechanisms. Subsequent investigations were able to adapt Bayesian forecasting test procedures to SWAP to diminish testing time to 3-4 min per eye, expand the dynamic range by more than 4 dB, and slightly reduce variability while…”